Christina Cotte, MD
she/her/hers
Hospital ResidentCards
About
Research
Publications
2022
Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019
Cotte C, Hartley-Brown M. Plasma cell leukemia: Retrospective review of cases at Monter Cancer Center/Northwell Health Cancer Institute, 2014-2019. Current Problems In Cancer 2022, 46: 100831. PMID: 35091270, DOI: 10.1016/j.currproblcancer.2021.100831.Peer-Reviewed Original Research
2021
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
Giannis D, Consortium O, Allen S, Tsang J, Flint S, Pinhasov T, Williams S, Tan G, Thakur R, Leung C, Snyder M, Bhatia C, Garrett D, Cotte C, Isaacs S, Gugerty E, Davidson A, Marder G, Schnitzer A, Goldberg B, McGinn T, Davidson K, Barish M, Qiu M, Zhang M, Goldin M, Matsagkas M, Arnaoutoglou E, Spyropoulos A. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood 2021, 137: 2838-2847. PMID: 33824972, PMCID: PMC8032474, DOI: 10.1182/blood.2020010529.Peer-Reviewed Original Research
2017
Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice
Cotte C, Szczepanek S. Peritoneal B-1b and B-2 B-cells confer long-term protection from pneumococcal serotype 3 infection after vaccination with Prevnar-13 and are defective in sickle cell disease mice. Vaccine 2017, 35: 3520-3522. PMID: 28545925, DOI: 10.1016/j.vaccine.2017.05.039.Peer-Reviewed Original Research
2016
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
Szczepanek S, Roberts S, Rogers K, Cotte C, Adami A, Bracken S, Salmon S, Secor E, Thrall R, Andemariam B, Metzger D. Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers. PLOS ONE 2016, 11: e0149261. PMID: 26910228, PMCID: PMC4766082, DOI: 10.1371/journal.pone.0149261.Peer-Reviewed Original ResearchORCID ID
0000-0002-8385-1921Peer-Reviewed Original Research